Skip to main content

Correction: TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer

The Original Article was published on 07 August 2024

Correction: J Exp Clin Cancer Res 43, 219 (2024)

https://doi.org/10.1186/s13046-024-03142-4

Following publication of the original article [1], the authors found out errors pertaining on the affiliations of the authors. The changes requested are highlighted in bold.

• Affiliation 2 should be changed from: “IRCCS Candiolo Cancer Institute, Candiolo, Italy” to “Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy”.

• Affiliation 5 should be updated from: “Department of Pharmacy, University of Napoli “Federico II”, Napoli, Italy” to “Department of Pharmacy, University of Napoli Federico II, Napoli, Italy”.

• Affiliation 7 should be updated from: “Medical University of Vienna, Vienna, Austria” to “Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria”.

These corrections do not affect the overall result or conclusion of the article. The original article [1] has been corrected.

References

  1. Akman M, Monteleone C, Doronzo G, et al. TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer. J Exp Clin Cancer Res. 2024;43:219. https://doi.org/10.1186/s13046-024-03142-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chiara Riganti.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s13046-024-03142-4.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Akman, M., Monteleone, C., Doronzo, G. et al. Correction: TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer. J Exp Clin Cancer Res 43, 244 (2024). https://doi.org/10.1186/s13046-024-03170-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13046-024-03170-0